AUG 03, 2020 1:56 PM PDT

Improving Diagnostics in Breast Cancer

WRITTEN BY: Jasper Cantrell

Diagnostics is one of the essential tools in a physician’s toolkit. A good diagnostic test can identify whether a patient has a disease, the severity of the disease, and what treatments might work best for that patient.

Breast cancer represents a perfect example of how effective diagnostics can be. Most breast cancers fall under HER2+, ER+, or PR+ subtypes.  Each can be diagnosed using a test and come with tailored treatments. These tests are usually immunohistochemistry assays. These assays stain for a particular protein and score the patient based on how much of said protein is there have been extremely useful in recent decades. A group from Qingdao University in affiliation with Quanticision Diagnostics developed a new assay that might be even more effective.  The quantum dot blot.

Their quantum dot blot uses a special nitrocellulose plate in the test instead of the standard plate normally used. Nitrocellulose binds proteins better than the standard plates. They would also utilize fluorescence instead of standard staining, which would speed up the analysis portion of the test. Both of these combined would make a faster test that needed less of the patient’s sample.

In this study, they intended to validate the quantum dot blot by comparing it to the available immunohistochemistry tests. They developed a simple protocol similar to immunohistochemical tests and used HER2+ or HER2- patients as the test group. The quantum dot blot identified HER2+ samples just as well as immunohistochemistry testing. Using a “gold standard” method called FISH, they further validated that the QDB test could identify HER2+ samples with just as much accuracy as current testing methods.

Not to waste an opportunity, the team decided to analyze HER2+ test results, and identify any correlations. They found that grade three patients were five-fold more likely to have a HER2+ tumor than grade one. This may be due to lapses in treatment, as HER2+ therapies are relatively standard nowadays, but the team did not elaborate on their findings.

The study states, “To the best of our knowledge, this is the first time protein biomarker was measured absolutely and quantitatively in FFPE samples using an immunoassay.” Improvements to the methodology are a hallmark of science and help improve testing in labs and the hospital. The quantum dot blot test outlined in this study decreases the amount of patient sample needed and speeds up the process. The fluorescent reporter also makes quantitative, rather than qualitative results, which can reduce bias from doctors or lab technicians.

All-in-all, this study shows the quantum dot blot improves upon current immunohistochemical diagnostic tests. New tests like this often experience a slow implementation, as they sometimes need non-standard reagents and intensive validation. Still, with any luck, it can make the diagnosis of HER2+ breast cancer and other diseases more efficient.

Sources: Nature Scientific Reports, Vector Laboratories Inc
 

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
NOV 11, 2020
Cell & Molecular Biology
Visualizing a Tumor Suppressor in Action
NOV 11, 2020
Visualizing a Tumor Suppressor in Action
Many types of cells in our bodies are short-lived and need to be replenished. Cell division has to be carefully controll ...
DEC 27, 2020
Immunology
A Fatty Diet can be Fuel for Tumor Growth!
DEC 27, 2020
A Fatty Diet can be Fuel for Tumor Growth!
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 05, 2021
Cancer
Two gene expression subtypes identified in peritoneal carcinomatosis cells
JAN 05, 2021
Two gene expression subtypes identified in peritoneal carcinomatosis cells
New research published in Nature Medicine finds two subtypes of gene expression in peritoneal carcinomatosis (PC) that c ...
JAN 11, 2021
Cancer
Sentinel Nodes Could Reveal a Tumor's Prognosis
JAN 11, 2021
Sentinel Nodes Could Reveal a Tumor's Prognosis
For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on ...
JAN 21, 2021
Cancer
Whole body MRI shown to be most sensitive in detecting myeloma
JAN 21, 2021
Whole body MRI shown to be most sensitive in detecting myeloma
New research suggests that whole body magnetic resonance imaging (WBMRI) is a more effective detection method than other ...
Loading Comments...